Re: a $6 sell order drops ZEN 96% !

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10734 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: a $6 sell order drops ZEN 96% !

in response to

Re: a $6 sell order drops ZEN 96% !

Nextblockbuster

posted on May 02, 2024 06:24AM

The day-to-day share price swings of "ZHCLF" on the OTC exchange do not matter.

What matters is "a royalty or partnership deal" for "ZHCLF" when we are not on a proper exchange that provides us with stock liquidity as we see fit.